Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : World Outlook -- Ignore unavailable to you. Want to Upgrade?

To: Les H who wrote (38780)	10/17/2023 10:17:35 AM
From: Les H	Respond to of 51028

One in 10 patients with autoimmune rheumatic disease flared after COVID-19 vaccination “Disease flares are one of the prominent concerns that patients with rheumatic diseases have, as these episodes are often accompanied by disabling symptoms that affect their day-to-day activities and quality of life,” Kshitij Jagtap, MD, of the Seth Gordhandas Sunderdas Medical College, in Mumbai, India, Parikshit Sen, MBBS, of Maulana Azad Medical College, in New Delhi, India, and Latika Gupta, MD, of the University of Manchester, in the United Kingdom, told Healio in a joint statement. “This has been one of the reasons why many of these patients are reluctant to get vaccinated against COVID-19, as there is a lingering fear that vaccines may precipitate these flares,” they added. “Unfortunately, there were very few studies that had investigated this relationship between COVID-19 vaccines and disease flares and thus there was no credible data to alleviate these concerns.” healio.com Only about 30% of RA patients choose to get vaccinated. The more severe the RA, the better the chance for a severe reaction to the vaccine. Vaccine is calibrated to prep you for a severe infection, while an infection is hit-or-miss depending on the exposure.